{"filings":[{"id":105892,"accession_number":"0001437749-26-001119","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Gyrodyne amends Flowerfield sale agreement with $1.52M credit, extends covenant deadline to Feb 5, 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Second Amendment provides $1,520,222 credit to B2K for on-site improvements on Lots 1 and 3 of Flowerfield.","Investigation period expired; B2K's right to terminate under Section 3.1(D) is null and void.","Parties must resolve third-party land use covenants by Feb 5, 2026; B2K may terminate if unresolved.","Sanitary flow chart revised, allocating all remaining sanitary flow to B2K except for Lots 1-3.","Company states impact on timeline and net asset value is premature to determine due to covenant uncertainty."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":122153,"accession_number":"0001437749-25-033874","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2025-11-07T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Gyrodyne LLC announces shareholder voting results from 2025 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Richard B. Smith elected as director with 1,394,282 votes for and 29,759 withheld.","Non-binding advisory vote on executive compensation approved: 1,392,477 for, 31,202 against.","Ratification of Baker Tilly US as auditor for 2025 fiscal year: 1,438,045 for, 284 against.","Broker non-votes totaled 38,531 on director election and compensation proposals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":122152,"accession_number":"0001437749-25-033184","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Gyrodyne CEO provides operational update; Flowerfield parcel sale for $28.74M targeted end of 2027","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 49 undeveloped acres of Flowerfield to B2K Development for $28.74M; close expected end 2027 subject to litigation & approvals.","Proforma NAV per share fell to $14.83 at June 2025 from $15.98 at Dec 2023; total NAV rose to $32.6M due to rights offering.","First half 2025 costs exceeded operating receipts by ~$700k, up $125k from 2024; occupancy 85% vs 86%.","Cortlandt Manor property has MOD designation; exploring mixed-use with residential to improve marketability.","Article 78 litigation hearing date awaited; decision expected in 2027. Board reduced to 4, chairman fee capped at $65k."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":122151,"accession_number":"0001437749-25-031273","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2025-10-17T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Gyrodyne settles with Star Equity; board reduced to four, Star Equity withdraws nominations","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Star Equity withdraws June 4, 2025 board nominations; board size cut from five to four.","Richard Smith sole nominee at 2025 annual meeting; director fees frozen, chairman cap $65k.","Star Equity agrees to standstill until Dec 31, 2026 (or Dec 31, 2027 if certain directors renominated).","Separate pact with Leap Tide includes voting commitment and standstill until 2028 annual meeting.","Director Paul Lamb, 28-year board member, will not stand for re-election."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138877,"accession_number":"0001437749-25-024553","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2025-08-04T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Gyrodyne signs agreement to sell 49-acre parcel for up to $28.74M; NAV per share rises to $14.83","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Purchase price range $24M-$28.74M, estimated final price $28.74M; buyer B2K Smithtown LLC.","Estimated NAV as of June 30, 2025: $32.6M ($14.83/share), up 6% from Q1 NAV of $30.8M ($14.01).","Sale expected to close by Dec 2027 (or Aug 2028 with extensions); liquidation timeline extended to Dec 31, 2027.","Transaction preserves >40% open space; includes assisted living facilities proposed by buyer.","JLL Capital Markets arranged the sale; deal includes customary conditions and contingencies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191744,"accession_number":"0001437749-24-031299","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2024-10-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"NY Supreme Court dismisses Article 78 petition against Gyrodyne's Flowerfield subdivision approval","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["On October 11, 2024, the NY Supreme Court ruled in favor of Gyrodyne, dismissing the Article 78 petition challenging the 8-lot subdivision of its Flowerfield property.","Justice Maureen T. Liccione found the petition defective and the Planning Board took the requisite hard look under SEQRA.","Gyrodyne continues seeking final subdivision approval and is conducting a national marketing effort via JLL Capital Markets to sell the property with entitlements.","CEO Gary Fitlin called the decision a major milestone that reaffirms the company's commitment to unlocking Flowerfield's value for shareholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191743,"accession_number":"0001437749-24-031068","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2024-10-11T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Gyrodyne LLC reports 2024 annual meeting voting results","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Director Ronald J. Macklin elected with 1,030,041 for, 325,673 withheld, and 585,051 broker non-votes.","Say-on-pay approved: 1,061,249 for, 283,493 against, 10,972 abstain (broker non-votes 585,051).","Baker Tilly US, LLP ratified as auditor for 2024: 1,816,419 for, 119,241 against, 5,105 abstain.","Turnout: 88.24% of 2,199,308 outstanding shares represented at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191742,"accession_number":"0001437749-24-030773","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2024-10-07T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Gyrodyne CEO: $4.4M rights offering, NAV per share $16.09, Flowerfield entitlements expected late 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Rights offering oversubscribed 65%, net proceeds $4.4M to defend Article 78 litigation and negotiate from strength.","Proforma NAV per share $16.09 at June 2024, down from $17.45 at Dec 2022, but total NAV increased ~$5M to $35.4M.","Occupancy 82% as of June 2024 (down from 85% Dec 2022); annual burn rate ~$1.3M ex-land development and litigation costs.","Debt of $11.3M fixed at 3.75%-3.85% through 2027/2028, largely unaffected by rate hikes.","CEO hopeful for final Flowerfield entitlements late 2024; JLL marketing both properties; open to sale of company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244926,"accession_number":"0001437749-24-007209","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2024-03-11T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Gyrodyne closes oversubscribed rights offering, raises $5M gross","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $5M from sale of 625,000 shares at $8 per share; net proceeds ~$4.4M.","Rights offering oversubscribed by ~65% (1,031,640 total shares subscribed vs 625,000 offered).","Basic subscriptions 353,164; over-subscription shares 271,836 allocated pro rata at ~40% of requests.","Net proceeds to fund liquidation process, defend Article 78 proceeding, and pay activist-related legal fees.","Shares issued in uncertificated book-entry form."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}